ASHISH KHOT
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- SPRINGFIELD, NJ
- NPI
- 1871822619
- Received
- $88,440 in 601 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 77 | $13,204 |
| 2024 | General payment | 88 | $22,750 |
| 2023 | General payment | 108 | $38,411 |
| 2022 | General payment | 73 | $9,652 |
| 2021 | General payment | 59 | $991 |
| 2020 | General payment | 56 | $1,059 |
| 2019 | General payment | 140 | $2,370 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 24 | $60,412 |
| Food and Beverage | 520 | $10,667 |
| Travel and Lodging | 28 | $7,297 |
| Compensation for serving as faculty or as a speaker for a medical education program | 3 | $4,590 |
| Honoraria | 2 | $2,960 |
| Consulting Fee | 1 | $1,455 |
| Education | 21 | $1,029 |
| Debt forgiveness | 2 | $27 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | Janssen Biotech, Inc. | $22 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-12-10 | BeOne Medicines USA, Inc. | $19 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-12-04 | Kite Pharma, Inc. | $18 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-12-01 | PFIZER INC. | $35 | Travel and Lodging | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-12-01 | PFIZER INC. | $9 | Travel and Lodging | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-12-01 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-12-01 | PFIZER INC. | $2 | Travel and Lodging | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-11-22 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | ELAHERE Drug, ONCOLOGY | 2025 | |
| 2025-11-21 | PFIZER INC. | $3,275 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-11-19 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-11-14 | Daiichi Sankyo Inc. | $15 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-11-13 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-11-12 | Janssen Biotech, Inc. | $16 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-11-11 | PFIZER INC. | $2 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-10-24 | Daiichi Sankyo Inc. | $18 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-10-22 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-21 | Astellas Pharma US Inc | $15 | Travel and Lodging | Cash or cash equivalent | Padcev Drug, Oncology | 2025 | |
| 2025-10-17 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-10-15 | Astellas Pharma US Inc | $4,110 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Padcev Drug, Oncology | 2025 | |
| 2025-10-15 | Astellas Pharma US Inc | $751 | Travel and Lodging | Cash or cash equivalent | Padcev Drug, Oncology | 2025 | |
| 2025-10-15 | Astellas Pharma US Inc | $124 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2025 | |
| 2025-10-08 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-09-25 | Pharmacosmos Therapeutics Inc. | $17 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2025 | |
| 2025-09-25 | GENZYME CORPORATION | $13 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-09-25 | PFIZER INC. | $1 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-09-24 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-09-18 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-09-16 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-09-11 | EMD Serono, Inc. | $14 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-09-10 | Regeneron Healthcare Solutions, Inc. | $15 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-09-05 | Daiichi Sankyo Inc. | $13 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-08-21 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-08-14 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-08-08 | Exelixis Inc. | $20 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-08-06 | Astellas Pharma US Inc | $17 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2025 | |
| 2025-07-24 | GENZYME CORPORATION | $18 | Food and Beverage | In-kind items and services | AYVAKIT Biological, Gastroenterology | 2025 | |
| 2025-07-23 | Novartis Pharmaceuticals Corporation | $6 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-07-22 | Janssen Biotech, Inc. | $29 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-07-17 | Janssen Biotech, Inc. | $139 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-07-17 | Exelixis Inc. | $19 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-07-16 | Daiichi Sankyo Inc. | $18 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-07-14 | Kite Pharma, Inc. | $14 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-07-12 | EMD Serono, Inc. | $13 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-07-11 | Astellas Pharma US Inc | $1,027 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Padcev Drug, Oncology | 2025 | |
| 2025-07-03 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-06-27 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-06-26 | Exelixis Inc. | $270 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-06-18 | Bayer Healthcare Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-06-04 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-05-28 | Aveo Pharmaceuticals, Inc. | $28 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-05-14 | Novartis Pharmaceuticals Corporation | $6 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-05-08 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-07 | Exelixis Inc. | $2,160 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-05-01 | Kite Pharma, Inc. | $16 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-05-01 | Exelixis Inc. | $15 | Travel and Lodging | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-04-30 | Exelixis Inc. | $124 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-04-24 | SOBI, INC | $18 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-04-23 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-16 | Exelixis Inc. | $16 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-04-10 | Rigel Pharmaceuticals, Inc. | $18 | Food and Beverage | Cash or cash equivalent | TAVALISSE Drug, Hematology | 2025 | |
| 2025-04-04 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-03-27 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-03-21 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-03-20 | Eisai Inc. | $19 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-03-18 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-03-13 | Alnylam Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | GIVLAARI Drug, Genetic Disease | 2025 | |
| 2025-02-26 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-02-13 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-02-10 | La Jolla Pharmaceutical Company | $97 | Food and Beverage | In-kind items and services | GIAPREZA Drug, EMERGENT HYPOTENSION | 2025 | |
| 2025-02-06 | EMD Serono, Inc. | $16 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-02-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-04 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2025 | |
| 2025-01-31 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-01-31 | PFIZER INC. | $4 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-01-23 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2025 | |
| 2025-01-17 | Geron Corporation | $14 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-01-16 | Daiichi Sankyo Inc. | $25 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2024-12-20 | Exelixis Inc. | $19 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-12-18 | Merck Sharp & Dohme LLC | $3,185 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-12-18 | Merck Sharp & Dohme LLC | $75 | Travel and Lodging | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-12-18 | TAIHO ONCOLOGY, INC. | $20 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2024 | |
| 2024-12-17 | Daiichi Sankyo Inc. | $17 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-12-13 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-12-12 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-12-11 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-12-04 | Merck Sharp & Dohme LLC | $540 | Travel and Lodging | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-12-04 | Merck Sharp & Dohme LLC | $125 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-12-04 | ADC THERAPEUTICS AMERICA, INC. | $28 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-02 | SpringWorks Therapeutics, Inc. | $20 | Food and Beverage | In-kind items and services | OGSIVEO Drug, DESMOID TUMORS | 2024 | |
| 2024-11-22 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | ELAHERE Drug, ONCOLOGY | 2024 | |
| 2024-11-14 | Pharmacosmos Therapeutics Inc. | $0 | Food and Beverage | In-kind items and services | COSELA Drug, HEMATOLOGY | 2024 | |
| 2024-11-12 | Pharmacosmos Therapeutics Inc. | $19 | Food and Beverage | In-kind items and services | COSELA Drug, HEMATOLOGY | 2024 | |
| 2024-11-12 | ARRAY BIOPHARMA INC | $17 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2024 | |
| 2024-11-08 | Mirati Therapeutics, Inc. | $19 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-11-05 | Astellas Pharma US Inc | $2 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2024 | |
| 2024-11-02 | Exelixis Inc. | $19 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-10-30 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2024 | |
| 2024-10-23 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-10-16 | Ferring Pharmaceuticals Inc. | $124 | Food and Beverage | In-kind items and services | ADSTILADRIN Biological, ONCOLOGY | 2024 | |
| 2024-10-14 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-10-10 | Ferring Pharmaceuticals Inc. | $33 | Food and Beverage | In-kind items and services | ADSTILADRIN Biological, ONCOLOGY | 2024 | |
| 2024-10-03 | TAIHO ONCOLOGY, INC. | $20 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2024 | |
| 2024-10-02 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-10-01 | Exelixis Inc. | $2,160 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-09-25 | Exelixis Inc. | $67 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-09-25 | Genetix Biotherapeutics Inc | $19 | Food and Beverage | In-kind items and services | LYFGENIA Drug, sickle-cell | 2024 | |
| 2024-09-09 | Pharmacosmos Therapeutics Inc. | $12 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2024 | |
| 2024-08-28 | EMD Serono, Inc. | $16 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-08-21 | BeiGene USA, Inc. | $20 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2024 | |
| 2024-08-16 | Daiichi Sankyo Inc. | $13 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-08-16 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-08-14 | Incyte Corporation | $21 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2024 | |
| 2024-07-24 | Merck Sharp & Dohme LLC | $16 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-07-23 | Astellas Pharma US Inc | $3,425 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Padcev Drug, Oncology | 2024 | |
| 2024-07-23 | Astellas Pharma US Inc | $101 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2024 | |
| 2024-07-18 | Astellas Pharma US Inc | $10 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2024 | |
| 2024-07-17 | Exelixis Inc. | $55 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-07-17 | Daiichi Sankyo Inc. | $16 | Food and Beverage | In-kind items and services | Vanflyta Drug, ONCOLOGY | 2024 | |
| 2024-07-10 | Sumitomo Pharma America, Inc. | $15 | Food and Beverage | In-kind items and services | ORGOVYX Drug, HORMONE THERAPY | 2024 | |
| 2024-06-13 | PFIZER INC. | $3,425 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PADCEV Biological, Oncology | 2024 | |
| 2024-06-13 | PFIZER INC. | $747 | Travel and Lodging | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-06-13 | PFIZER INC. | $117 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-06-12 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2024 | |
| 2024-06-12 | PFIZER INC. | $1 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2024 | |
| 2024-06-12 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2024 | |
| 2024-06-11 | ARRAY BIOPHARMA INC | $9 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2024 | |
| 2024-06-08 | Exelixis Inc. | $14 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-06-08 | Exelixis Inc. | $4 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-06-06 | BeiGene USA, Inc. | $26 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2024 | |
| 2024-05-30 | Medtronic, Inc. | $136 | Food and Beverage | In-kind items and services | INTERSTIM Device, Sacral Nerve Stimulation | 2024 | |
| 2024-05-29 | Bayer Healthcare Pharmaceuticals Inc. | $26 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2024 | |
| 2024-05-28 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-05-17 | Mirati Therapeutics, Inc. | $28 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-05-10 | Exelixis Inc. | $14 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-05-10 | Exelixis Inc. | $1 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-05-08 | Astellas Pharma US Inc | $14 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2024 | |
| 2024-05-01 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2024 | |
| 2024-05-01 | PFIZER INC. | $16 | Education | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2024 | |
| 2024-04-25 | Eisai Inc. | $18 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2024 | |
| 2024-04-19 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2024 | |
| 2024-04-17 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-03-27 | BeiGene USA, Inc. | $16 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2024 | |
| 2024-03-20 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2024 | |
| 2024-03-15 | Takeda Pharmaceuticals U.S.A., Inc. | $15 | Food and Beverage | In-kind items and services | ALUNBRIG Drug, ONCOLOGY | 2024 | |
| 2024-03-14 | Exelixis Inc. | $1,715 | Honoraria | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-03-07 | Exelixis Inc. | $190 | Travel and Lodging | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-03-07 | Exelixis Inc. | $110 | Travel and Lodging | Cash or cash equivalent | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-03-06 | SERVIER PHARMACEUTICALS LLC | $14 | Food and Beverage | In-kind items and services | Tibsovo Drug, Oncology | 2024 | |
| 2024-02-23 | Genentech USA, Inc. | $15 | Food and Beverage | In-kind items and services | Columvi Biological, BioOncology | 2024 | |
| 2024-02-21 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-02-21 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2024 | |
| 2024-02-13 | Astellas Pharma US Inc | $892 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Padcev Drug, Oncology | 2024 | |
| 2024-02-08 | PFIZER INC. | $2,975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PADCEV Biological, Oncology | 2024 | |
| 2024-02-08 | PFIZER INC. | $125 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-02-08 | PFIZER INC. | $20 | Travel and Lodging | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-01-31 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2024 | |
| 2024-01-29 | Pharmacosmos Therapeutics Inc. | $108 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2024 | |
| 2024-01-24 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | ADCETRIS Biological, Oncology | 2024 | |
| 2024-01-24 | Exelixis Inc. | $15 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-01-17 | PFIZER INC. | $1,245 | Honoraria | Cash or cash equivalent | PADCEV Biological, Oncology | 2024 | |
| 2024-01-16 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2024 | |
| 2024-01-10 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-01-09 | Incyte Corporation | $20 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2024 | |
| 2024-01-04 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2024 | |
| 2024-01-03 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2024 | |
| 2023-12-20 | Merck Sharp & Dohme LLC | $3,185 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-12-20 | Blueprint Medicines Corporation | $15 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2023 | |
| 2023-12-12 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2023 | |
| 2023-12-08 | SEAGEN INC. | $5 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2023 | |
| 2023-12-06 | Merck Sharp & Dohme LLC | $25 | Travel and Lodging | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-12-05 | Merck Sharp & Dohme LLC | $93 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-11-29 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-21 | Merck Sharp & Dohme LLC | $25 | Travel and Lodging | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-11-14 | Astellas Pharma US Inc | $2,975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Padcev Drug, Oncology | 2023 | |
| 2023-11-14 | Astellas Pharma US Inc | $124 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2023 | |
| 2023-11-14 | Astellas Pharma US Inc | $41 | Travel and Lodging | Cash or cash equivalent | Padcev Drug, Oncology | 2023 | |
| 2023-11-08 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2023 | |
| 2023-10-30 | Bayer Healthcare Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2023 | |
| 2023-10-25 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2023 | |
| 2023-10-25 | Eisai Inc. | $14 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2023 | |
| 2023-10-16 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-10-04 | Exelixis Inc. | $3,185 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CABOMETYX Drug, Oncology | 2023 | |
| 2023-10-04 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2023 | |
| 2023-09-28 | Exelixis Inc. | $1,065 | Travel and Lodging | In-kind items and services | CABOMETYX Drug, Oncology | 2023 | |
| 2023-09-28 | Exelixis Inc. | $125 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Oncology | 2023 | |
| 2023-09-25 | Merck Sharp & Dohme LLC | $16 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-09-20 | Mirati Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | KRAZATI Drug, ONCOLOGY | 2023 | |
| 2023-09-16 | Incyte Corporation | $1,455 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-09-15 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2023 | |
| 2023-09-14 | SEAGEN INC. | $2,975 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PADCEV Biological, Oncology | 2023 | |
| 2023-09-14 | SEAGEN INC. | $683 | Travel and Lodging | In-kind items and services | PADCEV Biological, Oncology | 2023 | |
| 2023-09-14 | SEAGEN INC. | $108 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2023 | |
| 2023-09-11 | SERVIER PHARMACEUTICALS LLC | $15 | Food and Beverage | In-kind items and services | Tibsovo Drug, Oncology | 2023 | |
| 2023-09-08 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2023 | |
| 2023-09-06 | Astellas Pharma US Inc | $89 | Education | In-kind items and services | 2023 | ||
| 2023-09-05 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2023 | |
| 2023-08-28 | Daiichi Sankyo Inc. | $14 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2023 | |
| 2023-08-28 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2023 | |
| 2023-08-23 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2023 | |
| 2023-08-21 | Aveo Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2023 |
The latest 200 records of 601.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Springfield, NJ, county Union County, NJ, state New Jersey; placed by its city name.
| Measure | Place (city or town) Springfield, NJ | County Union County, NJ | State New Jersey |
|---|---|---|---|
| Population B01003 | 1,304 | 579,290 | 9,343,809 |
| Population, 2020 census P1 | 1,518 | 575,345 | 9,288,994 |
| Median age B01002 | 42.1 | 39.1 | 40.1 |
| Under 18 B01001 | 16.9% | 23.5% | 21.8% |
| 65 and over B01001 | 12.2% | 15.1% | 17.2% |
| Households B11001 | 437 | 203,277 | 3,507,701 |
| Foreign born B05002 | 45.6% | 33.6% | 23.9% |
| Median household income B19013 | $250,001 | $103,202 | $103,556 |
| Median family income B19113 | $250,001 | $125,330 | $127,025 |
| Per capita income B19301 | $96,657 | $52,874 | $54,253 |
| Poverty rate B17001 | 0.3% | 9.2% | 9.7% |
| Unemployment rate B23025 | 1.8% | 6.5% | 6.3% |
| Civilian labor force B23025 | 905 | 317,599 | 5,003,179 |
| Mean commute (minutes) B08013 | 22.5 | 30.2 | 30.5 |
| Bachelor's degree or higher B15003 | 59.1% | 38.9% | 43.6% |
| Housing units B25001 | 471 | 212,385 | 3,791,354 |
| Owner-occupied B25003 | 84.7% | 57.4% | 63.8% |
| Renters B25003 | 15.3% | 42.6% | 36.2% |
| Median home value B25077 | $607,900 | $529,200 | $454,400 |
| Median gross rent B25064 | $2,332 | $1,730 | $1,720 |
| White, not Hispanic B03002 | 20.9% | 35.4% | 50.9% |
| Black B03002 | 7.9% | 19.1% | 12.2% |
| Hispanic or Latino B03002 | 32.4% | 35.2% | 22.5% |
| Asian B03002 | 38.9% | 5.6% | 10.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Springfield, NJ.
Comments